Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 302 followers

Latest posts

Last updated about 1 hour ago

Eli Lilly helps struggling Sangamo with $1.4B gene therapy deal

about 1 hour ago

Sangamo Therapeutics has secured a licensing deal with Eli Lilly that helps...

Cell therapy biotech Neurona nabs $102M to push epilepsy candidate into phase 3

about 6 hours ago

The California biotech will use the cash infusion to support its pipeline...

Unlocking Genomic Data: How NashBio is Advancing Innovation in Life Sciences

about 8 hours ago

NashBio is transforming life sciences by making complex genomic and real-world data...

Siemens AG to acquire lab R&D platform Dotmatics for $5.1B

about 8 hours ago

The German conglomerate said the deal would not only add to its...

Roche shows most Alzheimer's patients below amyloid threshold after 28 weeks

about 10 hours ago

Roche has reported preliminary results on its Alzheimer’s disease prospect trontinemab. An...

Aldeyra’s dry eye drug suffers second FDA rejection, but imminent data spur hope of fast recovery

about 10 hours ago

The FDA has set back Aldeyra Therapeutics’ ambitions to win approval for...

BeiGene abandons ociperlimab over poor phase 3 prospects in latest blow to TIGITs

about 11 hours ago

BeiGene is scrapping ociperlimab over a disappointing phase 3 outlook two years...

Boehringer commits $31M to ADC R&D via new Swiss facility for NBE Therapeutics

about 14 hours ago

Boehringer Ingelheim is pumping funds into the still-hot antibody-drug conjugate (ADC) space...

Cyclacel Pharmaceuticals sheds clinical cancer asset in effort to stop cash spiral

about 16 hours ago

Struggling Cyclacel Pharmaceuticals is dropping one of its two clinical stage assets...

Concentra swoops in to buy struggling Allakos, softening the blow of other denied buyout attempts

1 day ago

Tang Capital Partners-owned Concentra inked an Allakos acquisition agreement after its other...

Elon Musk to step down from DOGE leadership role: Politico

1 day ago

In the upcoming weeks, Tesla CEO Elon Musk is expected to step...

‘Patently illegal’: NIH and HHS face new lawsuit over $1.1B in revoked research grants

1 day ago

The American Public Health Association and several researchers are suing the NIH...